301-315 of 2805
Optimizing Public Health Messaging: Lessons from the COVID-19 Response
Clinician's RoundtableOptimizing Public Health Messaging: Lessons from the COVID-19 Response
Targeted COVID-19 Messaging: Reaching At-Risk Communities
Clinician's RoundtableTargeted COVID-19 Messaging: Reaching At-Risk Communities
How the COVID-19 Pandemic Exposed Gaps in US Hospital Preparedness
Clinician's RoundtableHow the COVID-19 Pandemic Exposed Gaps in US Hospital Preparedness
Challenging Migraine Stereotypes: Improving Patient Care Through Empathy and Insight
On the Frontlines of MigraineChallenging Migraine Stereotypes: Improving Patient Care Through Empathy and Insight
Evaluating Guselkumab for Pediatric Psoriasis: New Phase III Trial Data
DermConsultEvaluating Guselkumab for Pediatric Psoriasis: New Phase III Trial Data
Genetics in Psoriasis: Impacts on Risk, Comorbidities, and Care
On the Frontlines of PsoriasisGenetics in Psoriasis: Impacts on Risk, Comorbidities, and Care
- advertisement
Decoding COPD: Precision Medicine Approaches for Complex Patient Profiles
On the Frontlines of COPDDecoding COPD: Precision Medicine Approaches for Complex Patient Profiles
The Future of Precision Medicine in COPD Care: Biomarkers, AI, and Multimodal Data
On the Frontlines of COPDThe Future of Precision Medicine in COPD Care: Biomarkers, AI, and Multimodal Data
Partnering for Better Hypertension Outcomes: How AMA and Azara Support Providers
Perspectives with the AMAPartnering for Better Hypertension Outcomes: How AMA and Azara Support Providers
Tuning the Brain: Personalized Anxiety Relief with Neurofeedback-Driven Headphones
NeuroFrontiersTuning the Brain: Personalized Anxiety Relief with Neurofeedback-Driven Headphones
Transforming Clinician Wellness: EEG Headphones Helping with Burnout
NeuroFrontiersTransforming Clinician Wellness: EEG Headphones Helping with Burnout
Navigating Gastrointestinal Impacts of GLP-1 Receptor Agonists
GI InsightsNavigating Gastrointestinal Impacts of GLP-1 Receptor Agonists
- advertisement
ECG Markers as Predictors of Adverse Outcomes in COPD: Insights from the IMPACT Trial
On the Frontlines of COPDECG Markers as Predictors of Adverse Outcomes in COPD: Insights from the IMPACT Trial
Scaling Success: Hypertension Control at MPCA with the AMA MAP™ Program
Perspectives with the AMAScaling Success: Hypertension Control at MPCA with the AMA MAP™ Program
New Frontiers in the Imaging and Treatment of Advanced Prostate Cancer
On the Frontlines of Prostate CancerNew Frontiers in the Imaging and Treatment of Advanced Prostate Cancer





























































